Joint supplement linked to Alzheimer's risk

A recent study has shown that taking glucosamine supplements, commonly used to alleviate joint pain, may be associated with an accelerated decline in the condition of Alzheimer’s patients and a 25% increase in the risk of death over five years, especially among individuals in the early stages of cognitive impairment. The research was based on medical records of approximately 24,000 dementia patients and over 41,000 individuals with mild cognitive impairment. It indicated that the effect of the medication might be linked to the accumulation of sugar chains on proteins and nerve cells. Despite these findings, the study emphasized that the relationship is not necessarily causal and that further research is needed to understand how glucosamine impacts cognitive health.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل